This Week – November 21, 2015
This Week in Washington, DC
From National Affairs Committee Chair, Whitfield L. Knapple, MD, FACG
Congress Must Pass the SCREEN Act
As you are aware, Medicare has finalized plans to significantly cut colonoscopy reimbursement beginning January 2016. Did you know that in anticipation for these cuts, the ACG has urged Congress to pass the SCREEN ACT (S.1079, H.R.2035) throughout 2015? The SCREEN Act would keep colonoscopy reimbursement at CY 2015 levels until the new Medicare reimbursement system begins in 2019.
Why should you and your legislators support the SCREEN Act?
The SCREEN Act is the only bill currently in Congress addressing these forthcoming cuts.
Read my full post to learn more and see what you can do to help.
The U.S. Food and Drug Administration on November 15, 2015 ordered Custom Ultrasonics to recall all of its automated endoscope reprocessors (AERs) from health care facilities due to the firm’s continued violations of federal law and a consent decree entered with the company in 2007. The identified violations could result in an increased risk of infection transmission. The FDA ordered this recall under the terms of the consent decree. The agency also issued a safety communication today recommending that health care facilities currently using Custom Ultrasonics AERs transition away from their use to alternative methods to reprocess flexible endoscopes as soon as possible.
Please visit the ACG’s FDA Related Matters Committee webpage to learn about FDA safety alerts impacting clinical GI.